The Clinical Potential of Matrix Metalloproteinase Inhibitors in the Rheumatic Disorders

ISSN： 1170-229X

Source： Drugs & Aging, Vol.18, Iss.2, 2001-02, pp. : 87-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrix Metalloproteinase Knockout Studies and the Potential Use of Matrix Metalloproteinase Inhibitors in the Rheumatic Diseases

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 363-375

Bentham Science Publishers

Access to resources Recommend Favorite

Curcumin: a potential candidate for matrix metalloproteinase inhibitors

By Kumar Dileep Kumar Manish Saravanan Chinnadurai Singh Sushil Kumar

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 959-972

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis

By George S.J.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. : 993-1007

Informa Healthcare

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1213-1216

Informa Healthcare

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors and cancer

By Lauer-Fields J.L. Fields G.B.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. : 1873-1884

Informa Healthcare

Access to resources Recommend Favorite